A comprehensive view of Metabolic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Fitch upgrades Sanofi's outlook to positive from stable, reflecting its transition toward innovative pharmaceutical company and vaccine producer, away from cardio-metabolic leader with rare disease franchise, broad portfolio of legacy off-patent drugs
Published: May 24, 2022 by ENP Newswire
Abbott releasing 12 metabolic nutrition formulas previously on hold free of charge to patients; products were on hold following recall of some powdered infant formulas, with product manufacturing to resume at Sturgis, Michigan, plant pending FDA approval
Published: May 02, 2022 by Abbott Laboratories
Resistant starches found to enrich beneficial gut microbes, helping to reduce fat, regulate blood glucose metabolism and insulin levels, protect gut; researchers conclude that resistant starches can be applied to produce functional foods for gut health
Published: April 05, 2022 by Food Chemistry
Abbott announces approval in Japan to expand reimbursement coverage for its FreeStyle Libre system to include all people with diabetes who use insulin at least once a day; device is a continuous glucose monitoring system
Published: March 24, 2022 by Abbott Laboratories
Scientists find biscuits containing isomaltulose sweetener and fortified with barley beta-glucans at 6% w/w lower cholesterol, increase faecal bulk and are considered 'highly acceptable' to consumers with glucose metabolism disorders such as diabetes
Published: March 04, 2022 by Food Hydrocolloids for Health

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count